The potential role of inhaled protozoa as a niche for intrapulmonary replication of Legionella pneumophila was investigated in vivo with mutant strains of L. pneumophila which have reduced virulence for the amoeba Hartmannella vermiformis. L. pneumophila AA488 and AA502 were derived from wild-type strain AA100 after transposon mutagenesis. These mutants have reduced virulence for H. vermiformis but are fully virulent for mononuclear phagocytic cells. A/J mice, which are susceptible to replicative L. pneumophila lung infections, were inoculated intratracheally with L. pneumophila AA100, AA488, or AA502 (10 6 bacteria per mouse) or were coinoculated with one of the L. pneumophila strains (10 6 bacteria per mouse) and uninfected H. vermiformis (10 6 amoebae per mouse). The effect of coinoculation with H. vermiformis on intrapulmonary growth of each L. pneumophila strain was subsequently assessed. In agreement with our previous studies, coinoculation with H. vermiformis significantly enhanced intrapulmonary growth of the parent L. pneumophila strain (AA100). In contrast, intrapulmonary growth of L. pneumophila AA488 or AA502 was not significantly enhanced by coinoculation of mice with H. vermiformis. These studies demonstrate that L. pneumophila virulence for amoebae is required for maximal intrapulmonary growth of the bacteria in mice coinoculated with H. vermiformis and support the hypothesis that inhaled amoebae may potentiate intrapulmonary growth of L. pneumophila by providing a niche for bacterial replication.
Legionella pneumophila is a bacterial parasite of many species of freshwater protozoa and an occasional intracellular pathogen of humans (2, 3, 21, 24, 26, 27, 29, 32, 36, 42) . Infection of humans with L. pneumophila usually occurs after bacteria from natural aquatic sources contaminate potable and nonpotable water systems. The portal of entry is the lung, via inhalation of aerosols or microaspiration of contaminated water (10, (14) (15) (16) . Following inhalation, the bacteria invade and replicate within host mononuclear phagocytic cells, primarily within alveolar macrophages. The intracellular infection of alveolar macrophages that is characteristic of Legionnaires' disease is remarkably similar in its ultrastructural features to L. pneumophila infection of protozoal organisms (1, 23, 24, 26, 32, 36, 40, 41) .
Since the discovery of the bacterium-protozoan interaction, there has been much speculation but limited research directed towards elucidating the relevance of protozoa to human L. pneumophila infection (36) . Protozoa play a key role in the persistence of L. pneumophila in natural aquatic water systems, since growth of L. pneumophila in the environment in the absence of these organisms has rarely been documented (22, 37, 43) . Protozoa may also serve as a vehicle to protect L. pneumophila through the process of water treatment and/or serve as a reservoir for growth of the bacteria in potable water systems (4) . Amoebae which are permissive for growth of L. pneumophila are frequently found in water implicated as the source of the bacteria in outbreaks of Legionnaire's disease (4, 10, 11, 19, 20) . It is not known whether the presence of amoebae is a prerequisite for an outbreak, since contamination of potable water systems with protozoa is exceedingly common (23, 36, 42) .
Using an animal model of replicative L. pneumophila lung infection in A/J mice inoculated intratracheally with virulent bacteria, we have recently demonstrated that protozoa may have a more direct effect on the pathogenesis of replicative L. pneumophila lung infection. Specifically, we have shown that intrapulmonary growth of L. pneumophila in A/J mice is potentiated by coinoculation with Hartmannella vermiformis, an amoebal species which is permissive for growth of the bacteria and a natural reservoir of L. pneumophila in the environment (7) . These results support the hypothesis that coincident inhalation of protozoa may enhance the severity of Legionnaire's disease. However, the mechanism(s) by which intrapulmonary H. vermiformis organisms potentiate L. pneumophila replication in vivo has not been thoroughly investigated.
In the present study, the potential role of intrapulmonary H. vermiformis as a niche for L. pneumophila replication was assessed with mutant strains of L. pneumophila which have reduced virulence for H. vermiformis and a previously described murine model of replicative L. pneumophila lung infection in A/J mice (8) . We demonstrate that bacterial virulence for H. vermiformis is required for maximal intrapulmonary growth of L. pneumophila in A/J mice coinoculated with the amoebae. These results support the hypothesis that intrapulmonary H. vermiformis organisms likely potentiate growth of L. pneumophila in vivo by their ability to provide a niche for L. pneumophila replication.
A virulent strain of L. pneumophila (AA100) originally isolated from an outbreak of Legionnaires' disease was used in all assays (8) . The bacteria were maintained and passaged on buffered charcoal-yeast extract (BCYE) agar (18) . The amoeba H. vermiformis CDC-19 (ATCC 50237), originally isolated from a water sample obtained during an investigation of nos-ocomial legionellosis, was maintained axenically as confluent monolayers of trophozoites in T-75 flasks in ATCC culture medium 1034 supplemented with 10% fetal bovine serum as previously described (19) .
To identify L. pneumophila mutants with reduced virulence for H. vermiformis, phosphatase-positive (Pho ϩ ) mutant strains of L. pneumophila were generated by transposon insertion mutagenesis of L. pneumophila AA100, with the previously described alkaline phosphatase fusion-generating transposon mTn10phoA (28) . The results of these experiments identified approximately 4,000 mutagenized legionellae, yielding 206 Pho ϩ L. pneumophila mutant bacterial strains. The ability of each Pho ϩ mutant L. pneumophila strain to grow in U937 cells (a human monocytic cell line which is permissive for L. pneumophila growth [12, 33] ) and H. vermiformis was subsequently assessed. Briefly, differentiated U937 cells were inoculated with the parent bacterial strain (AA100) or with a Pho ϩ strain of L. pneumophila at a multiplicity of infection (MOI) of 20:1 for 2 h at 37°C. L. pneumophila-infected U937 cell monolayers were then washed and incubated for an additional 2 h in media containing gentamicin (50 g/ml) to kill extracellular bacteria. The cells were subsequently washed and either immediately hypotonically lysed or incubated for an additional 24 to 72 h (37°C, 5% CO 2 ). Following incubation, the culture supernatant was removed, the cells were hypotonically lysed, and the corresponding cell supernatant and lysate were pooled. An aliquot of each sample was serially diluted in water and cultured on BCYE. The number of L. pneumophila CFU per sample, indicative of growth of Pho ϩ L. pneumophila mutants in U937 cells, was determined and compared to that of the parent L. pneumophila strain (AA100). To assess the virulence of each L. pneumophila strain for H. vermiformis, axenically maintained H. vermiformis monolayers were inoculated with each mutant L. pneumophila strain at an MOI of 1:1. Immediately after inoculation, an aliquot of the culture supernatant was removed and serially diluted, and L. pneumophila CFU in the inocula were determined. L. pneumophila-infected H. vermiformis monolayers were then incubated for 24 to 72 h, at which time an aliquot of the culture supernatant was removed and cultured on BCYE. The number of L. pneumophila CFU in culture supernatant, indicative of growth of Pho ϩ L. pneumophila mutants in H. vermiformis, was determined and compared to that of the parent L. pneumophila strain (AA100). As shown in Fig. 1 , these screening methods identified three Pho ϩ L. pneumophila strains, designated AA488, AA501, and AA502, which are as virulent as L. pneumophila AA100 for cultured mononuclear phagocytic cells but have significantly reduced virulence for H. vermiformis.
Virulence of L. pneumophila AA488, AA501, and AA502 in vivo was subsequently assessed with a previously described murine model of legionellosis in intratracheally inoculated A/J mice (8) . For preparation of in vivo inocula, each L. pneumophila strain was grown on BCYE agar for 48 h and resuspended in phosphate-buffered saline (4 ϫ 10 7 bacteria per ml). Female 6-to 8-week-old A/J mice (Jackson Laboratories, Bar Harbor, Maine), which are susceptible to replicative L. pneumophila lung infections (8) , were subsequently inoculated intratracheally with the parent bacterial strain (AA100) or with one of the three mutant L. pneumophila strains (10 6 bacteria per mouse) (8) . At 48 h postinoculation, the mice were humanely euthanized, the lungs were excised and homogenized, and L. pneumophila CFU per lung were determined by culture of lung homogenate on bacteriological media (8, 17) . (The mice were euthanized at this time point because the results of our previous studies have demonstrated that intrapulmonary growth of L. pneumophila AA100 in intratracheally inoculated A/J mice is maximal at 48 h postinoculation [8] .) As shown in Fig. 2 , while there was no significant difference between intrapulmonary growth of either L. pneumophila AA488 or AA502 and the parent bacterial strain (AA100), significantly fewer L. pneumophila CFU were recovered from lung homogenates of mice inoculated intratracheally with L. pneumophila AA501. These results demonstrate that L. pneumophila AA501 has reduced virulence in vivo. Consequently, this strain was eliminated from further analysis.
In subsequent experiments, the growth kinetics of L. pneumophila AA488, AA502, and AA100 in the lung were compared. A/J mice were inoculated intratracheally with either L. pneumophila AA488, AA502, or AA100 (10 6 bacteria per mouse). At 24 to 72 h postinoculation, the mice were humanely euthanized and L. pneumophila CFU in lung homogenates were determined by culture of lung homogenate on bacteriological media (8, 17) . As shown in Fig. 3 , the levels of intrapulmonary growth of L. pneumophila AA488 and AA502 were similar to that of L. pneumophila AA100. These results dem- ϩ L. pneumophila strains in differentiated U937 cells was monitored as previously described and compared to that of the parent bacterial strain (AA100). (B) Growth of Pho ϩ L. pneumophila strains in the amoeba H. vermiformis was determined as previously described and compared to that of the parent bacterial strain (AA100). Data for both panels A and B represent the mean log increase in CFU from duplicate wells of a minimum of two separate experiments. ‫,ء‬ significant difference in growth compared with that in L. pneumophila AA100 (Student's t test [P Ͻ 0.05]).
onstrate that L. pneumophila AA488 and AA502 are fully virulent in vivo.
The effect of coinoculation with H. vermiformis on the intrapulmonary growth of each L. pneumophila strain was subsequently assessed. A/J mice were inoculated intratracheally with the parent strain of L. pneumophila, AA100 (which is virulent for both mononuclear phagocytic cells and H. vermiformis [10 6 bacteria per mouse]), or with Pho ϩ L. pneumophila AA488 or AA502 (strains which are fully virulent for mononuclear phagocytic cells in vivo but have reduced virulence for H. vermiformis [10 6 bacteria per mouse]), or they were coinoculated with these bacterial strains (10 6 bacteria per mouse) and H. vermiformis (10 6 amoebae per mouse) as previously described (7, 8, 38) . At 48 h postinoculation, the mice were humanely euthanized and the lungs were excised and homogenized. L. pneumophila CFU per lung were determined by culture of lung homogenates on bacteriological media. Bacterial growth was assessed at 48 h postinoculation, because we have previously demonstrated that growth of L. pneumophila in mice coinoculated with H. vermiformis and strain AA100 is maximal at this time point (7) . In agreement with the results of our previous studies (7), coinoculation of A/J mice with H. vermiformis significantly enhanced intrapulmonary growth of the parent strain of L. pneumophila (AA100) ( Table 1 ). In contrast, coinoculation with H. vermiformis did not result in a significant increase in intrapulmonary growth of L. pneumophila AA488 or AA502 compared to that in mice inoculated with the same strain of bacteria alone. These results demonstrate that L. pneumophila virulence for H. vermiformis is required for maximal enhancement in intrapulmonary growth of the bacteria in mice coinoculated with the amoebae and support the hypothesis that intrapulmonary H. vermiformis may enhance growth of L. pneumophila in the lung by providing a niche for bacterial replication.
However, our results also demonstrate that there were small increases (i.e., three-and sixfold, respectively) in the growth of L. pneumophila in mice coinoculated with H. vermiformis and L. pneumophila AA488 or AA502 at 48 h postinfection compared to that in mice inoculated with the same strain of bacteria. While this increase in bacterial growth is not statistically significant, these results suggest that intrapulmonary H. vermiformis may potentiate the growth of L. pneumophila, at least in part, by a mechanism which is independent of L. pneumophila virulence for H. vermiformis. We have previously demonstrated that intrapulmonary H. vermiformis alters host immune responses during replicative L. pneumophila lung infections, resulting in exaggerated production of cytokines, including gamma interferon and tumor necrosis factor alpha (7). Previous studies by our laboratory and others have demonstrated that mononuclear phagocytic cell activation, mediated in large part by gamma interferon and tumor necrosis factor alpha, is required for resolution of replicative L. pneumophila infection in permissive mononuclear phagocytic cells (5, 6, 8, 9, 25, 31) . However, exaggerated production of proinflammatory cytokines, including tumor necrosis factor alpha, has been shown to be detrimental to resolution of other inflammatory lung diseases, including adult respiratory distress syndrome (30, 39) (7) . The results of our current study demonstrate that L. pneumophila virulence for H. vermiformis is required for maximal intrapulmonary growth of the bacteria. These results support the hypothesis that intrapulmonary amoebae may facilitate growth of L. pneumophila in the lung, at least in part, by providing a niche for bacterial replication in vivo. However, this mechanism is not mutually exclusive, because H. vermiformis-induced changes in host immune responses and/or increased bacterial virulence, resulting from intra-amoebic growth of the bacteria, may also contribute to enhanced intrapulmonary growth of L. pneumophila.
While our results support a role of coinhaled protozoa in the pathogenesis of experimentally induced legionellosis, the potential role of inhaled amoebae in the pathogenesis of Legionnaires' disease in humans remains unknown. It is likely that people may inhale H. vermiformis, because amoebae can be aerosolized (35) and asymptomatic persons frequently have titers of antibody to amoebal species, including H. vermiformis, indicative of human exposure (34) . However, it is likely impossible to validate a role of inhaled H. vermiformis in the pathogenesis of legionellosis in humans by identification of amoebae in the lung. We have previously demonstrated that H. vermiformis is identifiable in the murine lung only during the initial phase of replicative L. pneumophila lung infection (i.e., at Ͻ72 h postinoculation [7] ). Diagnostic tests of human patients suspected of having Legionnaires' disease are conducted considerably later in the course of the infection, potentially after inhaled amoebae have been cleared from the lung. Nevertheless, the results of our present studies indicate that further investigation into the potential role of coinhaled protozoa in the pathogenesis of Legionnaires' disease in humans is warranted. It is anticipated that the results of these studies may have significant implications with regard to the design of strategies to prevent, control, and/or treat human legionellosis.
